(-)-demecolcine increases expression ISO RGD:733714 6480464 Demecolcine results in increased expression of PPP2R2A mRNA CTD PMID:23649840 17alpha-ethynylestradiol increases expression ISO RGD:736551 6480464 Ethinyl Estradiol results in increased expression of PPP2R2A mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:736551 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R2A mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:733714 6480464 Estradiol affects the expression of PPP2R2A mRNA CTD PMID:22574217 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:733714 6480464 Metribolone promotes the reaction [NDRG1 protein binds to PPP2R2A protein] CTD PMID:17220478 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO RGD:733714 6480464 Metribolone results in decreased expression of PPP2R2A protein CTD PMID:17152098 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:736551 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:733714 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736551 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R2A mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PPP2R2A mRNA CTD PMID:33387578 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PPP2R2A mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PPP2R2A mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:733714 6480464 beta-methylcholine affects the expression of PPP2R2A mRNA CTD PMID:21179406 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PPP2R2A mRNA CTD PMID:19162173 acrylamide increases expression ISO RGD:733714 6480464 Acrylamide results in increased expression of PPP2R2A mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:736551 6480464 Aflatoxin B1 results in increased expression of PPP2R2A mRNA CTD PMID:19770486 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PPP2R2A mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:733714 6480464 Antirheumatic Agents results in increased expression of PPP2R2A mRNA CTD PMID:24449571 aristolochic acid decreases expression ISO RGD:733714 6480464 aristolochic acid I results in decreased expression of PPP2R2A mRNA CTD PMID:33212167 aristolochic acid increases expression ISO RGD:733714 6480464 aristolochic acid I results in increased expression of PPP2R2A protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:733714 6480464 arsenite promotes the reaction [G3BP1 protein binds to PPP2R2A mRNA] CTD PMID:32406909 atrazine increases expression ISO RGD:733714 6480464 Atrazine results in increased expression of PPP2R2A mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:733714 6480464 Benzo(a)pyrene results in increased expression of PPP2R2A mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733714 6480464 7 more ... CTD PMID:20018196 Benzo[k]fluoranthene decreases expression ISO RGD:736551 6480464 benzo(k)fluoranthene results in decreased expression of PPP2R2A mRNA CTD PMID:26377693 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PPP2R2A mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions ISO RGD:733714 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PPP2R2A gene CTD PMID:31601247 bortezomib increases expression ISO RGD:733714 6480464 Bortezomib results in increased expression of PPP2R2A mRNA CTD PMID:20977926 camptothecin multiple interactions ISO RGD:733714 6480464 PPP2R2A protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form] CTD PMID:25772433 camptothecin decreases response to substance ISO RGD:733714 6480464 PPP2R2A protein results in decreased susceptibility to Camptothecin CTD PMID:25772433 carbamazepine affects expression ISO RGD:733714 6480464 Carbamazepine affects the expression of PPP2R2A mRNA CTD PMID:24752500 cisplatin multiple interactions ISO RGD:733714 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PPP2R2A mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:736551 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PPP2R2A mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PPP2R2A mRNA] CTD PMID:17585979 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of PPP2R2A mRNA CTD PMID:15860345 copper atom multiple interactions ISO RGD:733714 6480464 [Chelating Agents binds to Copper] which results in increased expression of PPP2R2A mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:733714 6480464 [Chelating Agents binds to Copper] which results in increased expression of PPP2R2A mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:733714 6480464 Copper Sulfate results in increased expression of PPP2R2A mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:733714 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:733714 6480464 Cyclosporine results in increased expression of PPP2R2A mRNA CTD PMID:20106945 diclofenac affects expression ISO RGD:733714 6480464 Diclofenac affects the expression of PPP2R2A mRNA CTD PMID:24752500 diuron increases expression EXP 6480464 Diuron results in increased expression of PPP2R2A mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733714 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R2A mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733714 6480464 Doxorubicin results in decreased expression of PPP2R2A mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:733714 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:733714 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PPP2R2A protein CTD PMID:23301498 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PPP2R2A mRNA CTD PMID:17920746 ethanol increases degradation ISO RGD:736551 6480464 Ethanol results in increased degradation of PPP2R2A protein CTD PMID:32492475 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of PPP2R2A mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PPP2R2A mRNA CTD PMID:24136188 formaldehyde decreases expression ISO RGD:733714 6480464 Formaldehyde results in decreased expression of PPP2R2A mRNA CTD PMID:20655997 fulvestrant increases methylation ISO RGD:733714 6480464 Fulvestrant results in increased methylation of PPP2R2A gene CTD PMID:31601247 fulvestrant multiple interactions ISO RGD:733714 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PPP2R2A gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PPP2R2A mRNA CTD PMID:22061828 , PMID:33387578 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of PPP2R2A mRNA CTD PMID:15860345 ivermectin decreases expression ISO RGD:733714 6480464 Ivermectin results in decreased expression of PPP2R2A protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:733714 6480464 PPP2R2A protein affects the susceptibility to Josamycin CTD PMID:31915244 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of PPP2R2A mRNA CTD PMID:16393664 microcystin-LR affects expression EXP 6480464 cyanoginosin LR affects the expression of PPP2R2A protein CTD PMID:22000993 microcystin-LR decreases expression ISO RGD:733714 6480464 cyanoginosin LR results in decreased expression of PPP2R2A protein CTD PMID:27393157 microcystin-LR multiple interactions ISO RGD:733714 6480464 cyanoginosin LR results in increased expression of and affects the localization of PPP2R2A protein CTD PMID:23436320 mitomycin C decreases response to substance ISO RGD:733714 6480464 PPP2R2A protein results in decreased susceptibility to Mitomycin CTD PMID:25772433 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:733714 6480464 U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of PPP2R2A mRNA] CTD PMID:12710931 N-methyl-N'-nitro-N-nitrosoguanidine decreases response to substance ISO RGD:733714 6480464 PPP2R2A protein results in decreased susceptibility to Methylnitronitrosoguanidine CTD PMID:25772433 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PPP2R2A mRNA CTD PMID:20360939 nocodazole decreases response to substance ISO RGD:733714 6480464 PPP2R2A results in decreased susceptibility to Nocodazole CTD PMID:17724024 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:733714 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of PPP2R2A gene CTD PMID:30521419 paracetamol multiple interactions ISO RGD:736551 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PPP2R2A mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PPP2R2A mRNA] CTD PMID:17585979 paracetamol affects expression ISO RGD:736551 6480464 Acetaminophen affects the expression of PPP2R2A mRNA CTD PMID:17562736 paraquat increases expression ISO RGD:736551 6480464 Paraquat results in increased expression of PPP2R2A mRNA CTD PMID:21371552 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of PPP2R2A mRNA CTD PMID:16221955 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PPP2R2A mRNA CTD PMID:20360939 phenobarbital affects expression ISO RGD:733714 6480464 Phenobarbital affects the expression of PPP2R2A mRNA CTD PMID:19159669 pirinixic acid increases expression ISO RGD:736551 6480464 pirinixic acid results in increased expression of PPP2R2A mRNA CTD PMID:18301758 , PMID:23811191 riddelliine multiple interactions ISO RGD:733714 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPP2R2A mRNA CTD PMID:33884520 SB 431542 multiple interactions ISO RGD:733714 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R2A mRNA CTD PMID:27188386 serpentine asbestos decreases methylation ISO RGD:733714 6480464 Asbestos, Serpentine results in decreased methylation of PPP2R2A gene CTD PMID:29523930 sodium arsenite multiple interactions ISO RGD:733714 6480464 PPP2R2A protein affects the reaction [sodium arsenite results in decreased phosphorylation of TFE3 protein] CTD PMID:29945972 tetrachloromethane increases expression ISO RGD:736551 6480464 Carbon Tetrachloride results in increased expression of PPP2R2A mRNA CTD PMID:27339419 , PMID:31919559 trichostatin A increases expression ISO RGD:733714 6480464 trichostatin A results in increased expression of PPP2R2A mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:733714 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R2A mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:736551 6480464 Valproic Acid results in decreased expression of PPP2R2A mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:733714 6480464 Valproic Acid results in decreased expression of PPP2R2A mRNA CTD PMID:23179753 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PPP2R2A mRNA CTD PMID:23034163 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of PPP2R2A protein CTD PMID:22689922 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of PPP2R2A protein CTD PMID:22689922
